Is NVIVQ or RYLD a better dividend investment in 2026?

NVIVQ currently yields 540.54% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: NVIVQ offers higher current income.

What is the dividend yield difference between NVIVQ and RYLD?

NVIVQ has a forward dividend yield of 540.54% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 528.40 percentage points.

Home › Compare › NVIVQ vs RYLD

NVIVQ vs RYLD: Dividend Comparison 2026

NVIVQ yields 540.54% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NVIVQ wins by $112786.18M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NVIVQ

● Live price

540.54%

Share price

$0.37

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$112786.22M

Annual income

$82,692,515,806.61

Full NVIVQ calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — NVIVQ vs RYLD

📍 NVIVQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NVIVQ	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NVIVQ + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NVIVQ pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVIVQ

Annual income on $10K today (after 15% tax)

$45,945.95/yr

After 10yr DRIP, annual income (after tax)

$70,288,638,435.62/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, NVIVQ beats the other by $70,288,636,236.37/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVIVQ + RYLD for your $10,000?

NVIVQ: 50%RYLD: 50%

100% RYLD50/50100% NVIVQ

Portfolio after 10yr

$56393.13M

Annual income

$41,346,259,196.98/yr

Blended yield

73.32%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVIVQ buys

RYLD buys

No recent congressional trades found for NVIVQ or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNVIVQRYLD

Forward yield	540.54% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$112786.22M ✓	$44.5K
Annual income after 10y	$82,692,515,806.61 ✓	$2,587.35
Total dividends collected	$110217.05M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: NVIVQ vs RYLD ($10,000, DRIP)

Year	NVIVQ Portfolio	NVIVQ Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$64,754	$54,054.05	$11,914	$1,213.65	+$52.8K → NVIVQ
2	$396,410	$327,123.28	$14,099	$1,351.30	+$382.3K → NVIVQ
3	$2,295,726	$1,871,567.31	$16,580	$1,494.55	+$2.28M → NVIVQ
4	$12,586,137	$10,129,710.14	$19,384	$1,642.61	+$12.57M → NVIVQ
5	$65,369,349	$51,902,182.37	$22,535	$1,794.70	+$65.35M → NVIVQ
6	$321,877,325	$251,932,121.38	$26,063	$1,950.00	+$321.85M → NVIVQ
7	$1,503,762,535	$1,159,353,797.14	$29,995	$2,107.69	+$1503.73M → NVIVQ
8	$6,671,013,644	$5,061,987,731.83	$34,361	$2,266.99	+$6670.98M → NVIVQ
9	$28,124,961,234	$20,986,976,635.20	$39,194	$2,427.12	+$28124.92M → NVIVQ
10	$112,786,224,327	$82,692,515,806.61	$44,525	$2,587.35	+$112786.18M → NVIVQ

NVIVQ vs RYLD: Complete Analysis 2026

NVIVQ — Stock

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Full NVIVQ Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this NVIVQ vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVIVQ vs SCHD NVIVQ vs JEPI NVIVQ vs O NVIVQ vs KO NVIVQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.